Public health management of antiviral drugs during the 2009 H1N1 influenza pandemic: a survey of local health departments in California

Table 2 Allowable uses for publicly purchased antivirals (n = 31).

Allowable Use	n	(% of LHDs)
Treatment of ill persons	28	(90)
Post-Exposure Prophylaxis (PEP)	24	(77)
Pre-Exposure Prophylaxis (PrEP)	7	(23)
Allowable use determined by dispensing site	8	(26)
Other	2	(6)

Among the thirty-one local health departments (LHDs) reporting that publicly purchased antivirals were dispensed in their community, Table 2 summarizes the number and proportion of LHDs that allowed publicly purchased antivirals to be used for treatment, post-exposure prophylaxis, and pre-exposure prophylaxis

ISSN: 1471-2458